Literature DB >> 23748893

Colony forming unit endothelial cells do not exhibit telomerase alternative splicing variants and activity.

Armin Attar1,2,3, Mohsen Khosravi Maharlooi1,2, Sara Khoshkhou1,2, Ahmad Hosseini4, Mansoureh Jaberipour4, Arman Dehghan1,2, Ahmad Monabati5,6.   

Abstract

INTRODUCTION: Endothelial progenitor colony forming unit-endothelial cells (CFU-EC) were first believed to be the progenitors of endothelial cells, named endothelial progenitor cells. Further studies revealed that they are monocytes regulating vasculogenesis. The main hindrance of these cells for therapeutic purposes is their low frequency and limited replicative potentials. This study was undertaken to determine telomerase activity and alternative splicing variants in CFU-EC as a potential cause of limited replicative capacity in these cells.
METHODS: CFU-EC were isolated from peripheral blood using a standard cell culture assay. Colonies were detached mechanically and alternative splicing variant mRNA were evaluated using real-time PCR. Telomerase enzyme activity was assessed using telomerase repeat amplification protocol. The same procedures were done on the cancer cell line Calu6 as the positive control.
RESULTS: The cultured peripheral blood mononuclear cells formed colonies with spindle-shaped monocytic cells sprouted from the clusters. These morphological characteristics fulfill the definition of CFU-EC. Telomere length amplification protocol assay revealed no telomerase activity and real-time PCR showed no expression of telomerase enzyme mRNA in CFU-EC. Both parameters were significantly higher in the cancer cell line Calu6 taken as the positive control.
CONCLUSION: The absence of telomerase activity in the CFU-EC is a result of pre-transcriptional regulation of gene expression rather than other mechanisms for controlling telomerase activity such as post-transcriptional modifications. This finding can explain the limited proliferative activity of CFU-EC cells. We propose that absence of telomerase activity in CFU-EC can be attributable to their more mature monocytic nature that needs further investigations.

Entities:  

Keywords:  Telomerase; Endothelial cells; Hemangioblast; Alternative splicing

Mesh:

Substances:

Year:  2013        PMID: 23748893      PMCID: PMC3770257          DOI: 10.6091/ibj.1100.2013

Source DB:  PubMed          Journal:  Iran Biomed J        ISSN: 1028-852X


  29 in total

1.  The hTERTalpha splice variant is a dominant negative inhibitor of telomerase activity.

Authors:  L M Colgin; C Wilkinson; A Englezou; A Kilian; M O Robinson; R R Reddel
Journal:  Neoplasia       Date:  2000 Sep-Oct       Impact factor: 5.715

2.  Circulating endothelial progenitor cells, vascular function, and cardiovascular risk.

Authors:  Jonathan M Hill; Gloria Zalos; Julian P J Halcox; William H Schenke; Myron A Waclawiw; Arshed A Quyyumi; Toren Finkel
Journal:  N Engl J Med       Date:  2003-02-13       Impact factor: 91.245

3.  Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis.

Authors:  Jin Hur; Chang-Hwan Yoon; Hyo-Soo Kim; Jin-Ho Choi; Hyun-Jae Kang; Kyung-Kook Hwang; Byung-Hee Oh; Myoung-Mook Lee; Young-Bae Park
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-12-29       Impact factor: 8.311

4.  Relevance of monocytic features for neovascularization capacity of circulating endothelial progenitor cells.

Authors:  Carmen Urbich; Christopher Heeschen; Alexandra Aicher; Elisabeth Dernbach; Andreas M Zeiher; Stefanie Dimmeler
Journal:  Circulation       Date:  2003-10-27       Impact factor: 29.690

5.  Maternal endothelial progenitor colony-forming units with macrophage characteristics are reduced in preeclampsia.

Authors:  Carol Lin; Augustine Rajakumar; Daniel A Plymire; Vivek Verma; Nina Markovic; Carl A Hubel
Journal:  Am J Hypertens       Date:  2009-06-04       Impact factor: 2.689

6.  Possible regulation of telomerase activity by transcription and alternative splicing of telomerase reverse transcriptase in human melanoma.

Authors:  R Villa; C D Porta; M Folini; M G Daidone; N Zaffaroni
Journal:  J Invest Dermatol       Date:  2001-06       Impact factor: 8.551

7.  Retinoids down-regulate telomerase and telomere length in a pathway distinct from leukemia cell differentiation.

Authors:  F Pendino; M Flexor; F Delhommeau; D Buet; M Lanotte; E Segal-Bendirdjian
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-22       Impact factor: 11.205

8.  Regulation of telomerase activity by alternate splicing of human telomerase reverse transcriptase mRNA in a subset of neuroblastomas.

Authors:  M Krams; A Claviez; K Heidorn; G Krupp; R Parwaresch; D Harms; P Rudolph
Journal:  Am J Pathol       Date:  2001-11       Impact factor: 4.307

9.  Alternatively spliced variant deleting exons 7 and 8 of the human telomerase reverse transcriptase gene is dominantly expressed in the uterus.

Authors:  Y Yokoyama; X Wan; Y Takahashi; A Shinohara; T Tamaya
Journal:  Mol Hum Reprod       Date:  2001-09       Impact factor: 4.025

10.  Transcription and alternative splicing of telomerase reverse transcriptase in benign and malignant breast tumours and in adjacent mammary glandular tissues: implications for telomerase activity.

Authors:  Nadia Zaffaroni; Chiara Della Porta; Raffaella Villa; Claudio Botti; Simonetta Buglioni; Marcella Mottolese; Maria Grazia Daidone
Journal:  J Pathol       Date:  2002-09       Impact factor: 7.996

View more
  10 in total

1.  Expression Pattern of Telomerase Reverse Transcriptase (hTERT) Variants and Bcl-2 in Peripheral Lymphocytes of Systemic Lupus Erythematosus Patients.

Authors:  Armin Attar; Mohsen Khosravi Maharlooei; Mohammad Ali Nazarinia; Ahmad Hosseini; Zohre Bajalli; Yalda Sadat Moeini; Ahmad Monabati; Fatemeh Amirmoezi; Mansooreh Jaberipour; Mojtaba Habibagahi
Journal:  Iran J Pathol       Date:  2020-04-21

2.  Role of CD146 Enrichment in Purification of Stem Cells Derived from Dental Pulp Polyp.

Authors:  Maryam Sadat Tavangar; Seyed-Mojtaba Hosseini; Ali Dehghani-Nazhvani; Ahmad Monabati
Journal:  Iran Endod J       Date:  2017

3.  Purification of Stem Cells from Oral Pyogenic Granuloma Tissue.

Authors:  Ali Dehghani Nazhvani; Shamsedin Ahzan; Seyed-Mojtaba Hosseini; Armin Attar; Ahmad Monabati; Maryam Sadat Tavangar
Journal:  Open Dent J       Date:  2018-08-29

4.  Global longitudinal strain as an Indicator of cardiac Iron overload in thalassemia patients.

Authors:  Firoozeh Abtahi; Alireza Abdi; Saideh Jamshidi; Mehran Karimi; Mohammad Ali Babaei-Beigi; Armin Attar
Journal:  Cardiovasc Ultrasound       Date:  2019-11-04       Impact factor: 2.062

5.  AICAR and nicotinamide treatment synergistically augment the proliferation and attenuate senescence-associated changes in mesenchymal stromal cells.

Authors:  Mohammadhossein Khorraminejad-Shirazi; Mahsa Sani; Tahereh Talaei-Khozani; Mohammadreza Dorvash; Malihe Mirzaei; Mohammad Ali Faghihi; Ahmad Monabati; Armin Attar
Journal:  Stem Cell Res Ther       Date:  2020-02-03       Impact factor: 6.832

6.  Association of coronary artery dominance and mortality rate and complications in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.

Authors:  Amir Mikaeilvand; Ata Firuozi; Hosseinali Basiri; Aida Varghaei; Peyman Izadpanah; Javad Kojuri; Alireza Abdi-Ardekani; Armin Attar
Journal:  J Res Med Sci       Date:  2020-11-26       Impact factor: 1.852

7.  Low Dose Spironolactone Monotherapy in the Management of Stage I Essential Hypertension: A Pilot Randomized, Double-Blind, Placebo-Controlled Trial.

Authors:  Armin Attar; Amir-Abbas Sadeghi; Fatemeh Amirmoezi; Kamran Aghasadeghi
Journal:  Acta Cardiol Sin       Date:  2018-01       Impact factor: 2.672

8.  Absence of Correlation between Changes in the Number of Endothelial Progenitor Cell Subsets.

Authors:  Armin Attar; Kamran Aghasadeghi; Mohammad Ebrahim Parsanezhad; Bahia Namavar Jahromi; Mojtaba Habibagahi
Journal:  Korean Circ J       Date:  2015-07-24       Impact factor: 3.243

9.  Identification of Mesenchymal Stem Cell Marker STRO-1 in Oral Reactive Lesions by Immunofluorescence Method.

Authors:  Ali Dehghani Nazhvani; Seyed-Mojtaba Hosseini; Bita Tahoori; Maryam-Sadat Tavangar; Armin Attar
Journal:  J Dent (Shiraz)       Date:  2015-09

10.  The association of plasma high-sensitivity C-reactive protein level with rheumatic heart disease: The possible role of inflammation.

Authors:  Armin Attar; Parvin Marzban; Alireza Moaref; Kamran Aghasadeghi
Journal:  Indian Heart J       Date:  2017-08-26
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.